Trial Profile
Stricture Definition and Treatment (STRIDENT) Drug Therapy Study
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Oct 2022
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Purines
- Indications Crohn's disease
- Focus Therapeutic Use
- Acronyms STRIDENT
- 05 Oct 2022 According to ClinicalTrials.gov record, the recruitment status of this study is unknown because the information has not been verified recently (last verified OCT 2020).
- 23 May 2021 Results presented at the Digestive Disease Week 2021
- 22 Oct 2020 Planned End Date changed from 1 Sep 2020 to 1 Sep 2021.